Mon, Dec 22, 2014, 4:45 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

American Capital, Ltd. Message Board

sandy.criscione 102 posts  |  Last Activity: Dec 18, 2014 10:06 AM Member since: Aug 23, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    year-end rally & january effect

    by sandy.criscione Dec 12, 2014 11:30 AM
    sandy.criscione sandy.criscione Dec 18, 2014 10:06 AM Flag

    here!

    Sentiment: Buy

  • Oclaro 100G surely involved....

    China Unicom taps Coriant for 100G backbone upgrade
    December 15, 2014
    Lightwave Staff

    Optical transport vendor Coriant GmbH has notched another win with China Unicom to expand the operator's 100G backbone network linking the cities of Wuhan, Hefei, and Nanjing. China Unicom will deploy the Coriant hiT 7300 multi-haul transport platform as part of the fiber-optic network expansion.

    "We're constantly working to accelerate the expansion of our mobile communications network across China, while providing our customers with high-quality broadband communications and information services," said Guangquan Wang, director of network technology, Network Technology Research Institute, China Unicom. "For this network expansion, we chose the Coriant hiT 7300 solution because it enables us to support an upgrade without interrupting existing traffic. It also provides us with the flexibility to add capacity as network demands increase."

    Coriant says its hiT 7300 optical transport platform provides the China Unicom network with higher capacity, support for photonic mesh configurations, and scalability from 40G to 100G and beyond.

    Coriant's optical transport team has been working with China Unicom since 2006 (see, for example, "China Unicom selects Nokia Siemens Networks to deploy optical network").

    Sentiment: Buy

  • Reply to

    s&p upgrades acas

    by sandy.criscione Dec 14, 2014 4:10 PM
    sandy.criscione sandy.criscione Dec 14, 2014 4:11 PM Flag

    *DJ S&P Raises American Capital Ltd. Rtg To BB From BB-; Outlook Stable

    Dec 11, 2014 15:19:00 (ET)

    (MORE TO FOLLOW) Dow Jones Newswires

    December 11, 2014 15:19 ET (20:19 GMT)

    Copyright (c) 2014 Dow Jones & Company, Inc.

    Sentiment: Buy

  • sandy.criscione by sandy.criscione Dec 14, 2014 4:10 PM Flag

    bb from -bb

    Sentiment: Buy

  • sandy.criscione by sandy.criscione Dec 12, 2014 11:30 AM Flag

    coming!

    Sentiment: Buy

  • sandy.criscione by sandy.criscione Dec 12, 2014 11:29 AM Flag

    coming!

    Sentiment: Buy

  • sandy.criscione by sandy.criscione Dec 12, 2014 8:06 AM Flag

    There are a lot of people who borrowed a lot of money based on higher price levels and they’re going to need more capital," said Schwarzman (NYSE:BX) at a conference yesterday. "There’s going to be a fallout. It’s going to be one of the best opportunities we’ve had in many, many years.”

    Sentiment: Buy

  • Reply to

    New article on ACAS

    by ribi1 Dec 8, 2014 5:51 PM
    sandy.criscione sandy.criscione Dec 9, 2014 1:06 PM Flag

    yes $20-$22 is another very reasonable projected price range.
    my guess is somewhere in between.
    either way, a win-win for acas shareholders :)

    Sentiment: Buy

  • Reply to

    New article on ACAS

    by ribi1 Dec 8, 2014 5:51 PM
    sandy.criscione sandy.criscione Dec 8, 2014 6:04 PM Flag

    yes $21.75 to $26 is the projected price range.

    Sentiment: Buy

  • sandy.criscione sandy.criscione Dec 7, 2014 9:05 PM Flag

    PE=2 & 20

    Sentiment: Strong Buy

  • sandy.criscione by sandy.criscione Dec 4, 2014 9:23 AM Flag

    BETHESDA, Md., Dec. 4, 2014 /PRNewswire/ -- American Capital Equity III, LP ("ACE III") announced today that it has invested in Schulman Associates IRB Holding Company, Inc. ("Schulman" or the "Company"). Schulman is a leading independent Institutional Review Board ("IRB") that provides clinical trial oversight services to pharmaceutical firms, contract research organizations, hospitals and academic medical centers throughout the United States and Canada.

    "We are extremely pleased to announce ACE III's first platform investment since launching the fund earlier this year," said Justin DuFour, American Capital Equity Partner. "Schulman is an excellent example of the type of businesses we are targeting in ACE III - lower middle market companies with proven management teams, niche market leadership positions, stable recurring revenue streams and attractive growth potential."

    Founded in 1983 and based in Cincinnati, Ohio, Schulman is one of the largest IRBs in the United States. The Company primarily serves the pharmaceutical and medical device industries as a central IRB on research involving drugs, medical devices and biologics. Schulman reviews research protocols and consent documents from clinical trials to evaluate compliance with human subject protection regulations. Schulman is fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).

    "Over its 31 year history, Schulman has successfully grown into an industry leader in the protection of human subjects in clinical trials," said Eugene Krichevsky, American Capital Equity Partner. "With its best-in-class regulatory compliance record, extensive range of therapeutic expertise and differentiated technology platform, Schulman is poised to meet the growing IRB demand for complex, multi-site clinical trials."

    "We are very excited to partner with Michael Woods and the rest of the Schulman team," said Scott Kauffman, American Capital Equity Principal. "They have done a remarkable job in driving significant historical growth and we are confident in their ability to continue to deliver strong results going forward."

    "American Capital Equity's insights into the healthcare services industry and significant financial support will allow us to meet the needs of our clients and continue to execute our strategic plan," said Michael Woods, Schulman CEO.

    Sentiment: Buy

  • Reply to

    Teasdale Foods

    by gdfeyy45 Dec 3, 2014 3:45 PM
    sandy.criscione sandy.criscione Dec 3, 2014 6:06 PM Flag

    clearly you don't know acas' business model... best for you to take a gander at twitter or open sesame...

    Sentiment: Buy

  • Reply to

    FSL is BX's 2nd biggest holding...

    by sam_0534 Dec 3, 2014 12:44 PM
    sandy.criscione sandy.criscione Dec 3, 2014 5:34 PM Flag

    sam, you're constant pumping is a bit much even for my long-bx tastes.

    Sentiment: Buy

  • Louie, I think this is the beginning of a beautiful (and profitable) friendship... H. Bogart in Casablanca

    BETHESDA, Md., Dec. 3, 2014 /PRNewswire/ -- American Capital, Ltd. (ACAS) ("American Capital") announced today that it has invested $31.5 million to support the acquisition of Teasdale Foods, Inc. ("Teasdale") by affiliates of Snow Phipps Group, LLC. Teasdale is a leading provider of private label and branded bean and hominy products to the retail, food service and wholesale channels. American Capital's investment takes the form of a second lien term loan.

    "Teasdale is a recognized industry leader and the largest provider of both conventional store brand and organic store brand beans in the U.S., serving a large diversified customer base throughout the retail, foodservice and industrial channels," said Ryan Brauns, American Capital Managing Director and Head of Sponsor Finance. "This is our first time supporting a new Snow Phipps platform investment and we're delighted to partner with them in this business. Our Sponsor Finance Group continues to search for new opportunities to build relationships with private equity sponsors and support their new buyouts, refinancings, add-on acquisitions, dividend recapitalizations and growth opportunities."

    Sundip Murthy, who oversees consumer investing at Snow Phipps, stated: "We were impressed with the responsiveness and dedication of American Capital's Sponsor Finance Group. They proved to be a reliable financing partner and we hope to collaborate on future investment opportunities."

    Sentiment: Buy

  • reap profits in europe at bargain basement prices here in a couple of years then find next fertile ground and rinse, recycle & repeat. The bx winning formula...hitch your wagon to this horse. We're still near initial IPO price...what a bargain!!!!

    Sentiment: Strong Buy

  • AT&T (NYSE: T) has confirmed with the FCC in a letter that it will go forward with its plans to bring its fiber-to-the-premises (FTTP) GigaPower 1 Gbps service to 21 communities.

    "AT&T still plans to complete the major initiative we announced in April to expand our ultra-fast GigaPower fiber network in 25 major metropolitan areas nationwide, including 21 new major metropolitan areas," wrote Robert Quinn, senior vice president of federal regulatory and chief privacy officer for AT&T, in a letter to the FCC.

    Quinn's letter was written in response to the FCC's request that the service provider clarify a statement made by company CEO Randall Stephenson, who threatened to put the brakes on new FTTP investments until the regulator worked out the net neutrality issue.

    Sentiment: Buy

  • Reply to

    omg acas $1.35 february 2009

    by sandy.criscione Nov 22, 2014 9:55 PM
    sandy.criscione sandy.criscione Nov 26, 2014 8:01 AM Flag

    evr & mc are better examples, in my opinion.

    Sentiment: Buy

  • Reply to

    Being held down-manipulated- wants to spike higher

    by sheamanski Nov 25, 2014 12:28 PM
    sandy.criscione sandy.criscione Nov 25, 2014 5:44 PM Flag

    don't worry...it will get there...AND HIGHER!

    Sentiment: Buy

  • great news...let's start a new fund, then another, and another...

    Sentiment: Strong Buy

  • long-term acas holders would be crazy to sell and will want to grow with the spin-offs and accompanying dividends. even if there is the obligatory decline, the combined shares will rebound quickly above current acas nav and holders will reap steady dividends and growth as back in the pre-crisis days. remember $50 share price & $4 dividend! acas is stronger now than in 2008, past their debt problems and trying to enhance shareholder value with the spin-offs and new structures. i applaude their turn-around and efforts. $1.35 to $14.88....sweeeeet returns indeed. the horse will be out of the barn once the spin-offs are formally announced. ajimho

    Sentiment: Strong Buy

ACAS
14.66-0.04(-0.27%)4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.